Glomerular disease (nephrotic & nephritic)
Nephrology · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Glomerular disease presents along a spectrum from nephrotic (heavy proteinuria, oedema) to nephritic (haematuria, hypertension, AKI). Early recognition and biopsy guide immunosuppression and prevent irreversible loss.
Red flags
- Refer all suspected glomerulonephritis to nephrology; admit urgently for AKI with active urinary sediment, suspected RPGN or pulmonary-renal syndrome, or nephrotic syndrome with complications
- Anti-GBM and ANCA vasculitis need same-day discussion – outcome depends on speed
Assessment
Investigations
- Urine dipstick, urine PCR/ACR, microscopy for casts
- U&E, albumin, lipids, glucose, FBC
- Immunology: ANA/dsDNA, complement C3/C4, ANCA, anti-GBM, immunoglobulins/electrophoresis, hepatitis/HIV serology
- Renal USS
- Renal biopsy is usually definitive and often urgent in nephritic presentations
Management
- Nephrotic: salt restriction and loop diuretics for oedema, ACEi/ARB to reduce proteinuria, statin, anticoagulation if high risk; cause-specific immunosuppression (e.g. steroids for minimal change)
- Nephritic/RPGN: urgent biopsy and immunosuppression (corticosteroids, cyclophosphamide/rituximab, plasma exchange for anti-GBM/severe vasculitis); control BP
Disposition
Refer all suspected glomerulonephritis to nephrology; admit urgently for AKI with active urinary sediment, suspected RPGN or pulmonary-renal syndrome, or nephrotic syndrome with complications.
Complications & pitfalls
- Nephrotic: venous and arterial thromboembolism (renal vein thrombosis, PE), infection from immunoglobulin loss, AKI, hyperlipidaemia
- Nephritic/RPGN: rapid irreversible loss of renal function, pulmonary haemorrhage (anti-GBM/ANCA), malignant hypertension, end-stage kidney disease
Exam pearls
- Haematuria with red-cell casts, rising creatinine and hypertension is rapidly progressive glomerulonephritis until proven otherwise: a same-day nephrology call and biopsy can be the difference between recovery and dialysis.
- Monitoring & follow-up: Track proteinuria (PCR), albumin, eGFR and BP; response defines remission. Monitor immunosuppression toxicity (counts, glucose, infection, PJP prophylaxis). Vaccinate (pneumococcal). Long-term nephrology follow-up for relapse and progression.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.